Yahoo
XETRA - Delayed Quote EUR

Drägerwerk AG & Co. KGaA (DRW3.DE)

103.20 -1.60 (-1.53%)
At close: November 6 at 5:35:13 PM GMT+1
Chart Range Bar
Loading chart for DRW3.DE
  • Previous Close 104.80
  • Open 106.00
  • Bid 102.80 x 16300
  • Ask 103.20 x 9400
  • Day's Range 101.20 - 106.00
  • 52 Week Range 66.00 - 125.40
  • Volume 28,351
  • Avg. Volume 20,596
  • Market Cap (intraday) 1.936B
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) 11.44
  • EPS (TTM) 9.02
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 2.27 (2.20%)
  • 1y Target Est 110.25
  • Moby Rating Neutral

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. In addition, it offers patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. Further, the company offers alcohol and drug testing; diving equipment; fixed gas detectors; hazmat suits; portable gas detection; head and eye protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply, as well as provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Dr. Heinrich Dräger GmbH.

www.draeger.com

16,716

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

DRW3.DE
52.56%
DAX P (^GDAXI)
5.43%

1-Year Return

DRW3.DE
57.09%
DAX P (^GDAXI)
8.79%

3-Year Return

DRW3.DE
124.37%
DAX P (^GDAXI)
70.59%

5-Year Return

DRW3.DE
67.05%
DAX P (^GDAXI)
60.83%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 850.77M
Earnings --
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q2

FY26

Q3

FY26

0
200M
400M
600M
800M
1B
0.0%

Analyst Insights

View More

Analyst Price Targets

90.00 Low
110.25 Average
103.20 Current
135.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.72%

  • Return on Assets (ttm)

    5.05%

  • Return on Equity (ttm)

    10.48%

  • Revenue (ttm)

    3.59B

  • Net Income Avi to Common (ttm)

    169.59M

  • Diluted EPS (ttm)

    9.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    270.9M

  • Total Debt/Equity (mrq)

    21.23%

  • Levered Free Cash Flow (ttm)

    161.69M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: